This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Thu May 23, 2013 9:18 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Sat Oct 16, 2010 2:37 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1688
Image

Roche and Biogen Idec announced 24-week results from a phase II study of ocrelizumab in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease.

Ocrelizumab demonstrated a significant reduction in disease activity as measured by brain lesions and relapse rate. Patients with RRMS suffer from relapses and disabling symptoms caused by nerve damage which can significantly affect their quality of life.

“These efficacy results are amongst the most remarkable seen in a phase II RRMS study, and show that ocrelizumab may have the potential to offer benefits to patients with this disease”... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Positive mid-stage results for MS drug ocrelizumab

squiffy2

1

851

Sat Nov 13, 2010 10:34 am

dignan View the latest post

There are no new unread posts for this topic. Positive results - Phase 1B trial of possible MS drug AZ01

squiffy2

0

564

Wed Oct 19, 2011 3:19 am

squiffy2 View the latest post

There are no new unread posts for this topic. Positive top-line results from phase III BOTOX® studies

squiffy2

0

309

Fri Mar 30, 2012 3:16 am

squiffy2 View the latest post

There are no new unread posts for this topic. Brainsway reports positive results in MS study

squiffy2

0

478

Mon Oct 24, 2011 1:14 am

squiffy2 View the latest post

There are no new unread posts for this topic. Phase II study of oral Fingolimod(FTY720) in MS results

squiffy2

13

1662

Fri Jan 08, 2010 5:36 pm

Summer55 View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: